Paras Healthcare’s ₹1,450 Crore IPO: How Debt Repayment and Expansion Compete for Capital

For a capital-intensive business, raising equity is not just about financing the next stage of growth. It can also be an opportunity to reduce borrowing obligations and create more room for future investment.

Paras Healthcare’s upcoming initial public offering illustrates this balancing act.

On 15 October 2026, the hospital operator announced a price band of ₹660 to ₹693 per share for its ₹1,450 crore IPO, scheduled to open on 21 October and close on 23 October.

The offering comprises a ₹500 crore fresh issue and a ₹950 crore offer for sale by existing shareholders. The fresh issue is particularly relevant to the company’s financial position because it brings new capital into the business.

Paras Healthcare intends to use ₹375 crore of the fresh issue proceeds towards repayment or prepayment of borrowings. The remaining ₹125 crore is allocated to general corporate purposes.

The proposed transaction offers a useful case study in the relationship between equity fundraising, debt reduction and the funding needs of a growing healthcare business.

Fresh Issue and Offer for Sale: Why the Difference Matters

An IPO can contain two distinct components.

A fresh issue creates new shares and raises capital for the issuing company. The funds may be used for specified purposes such as debt repayment, capital expenditure or working capital.

An offer for sale (OFS) involves existing shareholders selling their shares. The sale proceeds generally go to those selling shareholders rather than to the company.

Paras Healthcare’s proposed ₹1,450 crore issue comprises ₹500 crore of fresh equity and ₹950 crore of OFS.

This distinction matters when analysing the financial effect of an IPO. The total issue size does not represent the amount of new capital that becomes available to fund the company’s operations or reduce its debt.

For a business assessing a public issue, the more relevant questions are how much fresh capital it will receive, how that capital will be deployed and how much debt will remain afterwards.

Why Debt Repayment Is Part of the Fundraising Plan

Paras Healthcare has earmarked ₹375 crore of fresh issue proceeds for debt repayment or prepayment.

Of this amount, ₹320.90 crore is intended for borrowings at the company itself, while ₹54.10 crore is intended to be invested in its wholly owned subsidiary, Plus Medicare Hospitals, to repay or prepay borrowings associated with its Srinagar hospital.

According to reporting by Fortune India, the company’s borrowings stood at approximately ₹1,393.86 crore as of 31 March 2026 and ₹1,429.49 crore as of 30 June 2026.

These figures provide context for the proposed repayment, but the ultimate effect on leverage will depend on the debt actually repaid, other changes in borrowings, and the company’s financial position after the IPO.

Debt reduction can help lower future interest obligations and reduce refinancing requirements. However, it does not remove the need to fund ongoing operations and planned expansion.

A Financial Turnaround, With Further Funding Requirements

Paras Healthcare reported a significant improvement in profitability in FY2026.

Its earnings before interest, taxes, depreciation and amortisation (EBITDA) rose to approximately ₹335.58 crore in FY2026 from ₹156.46 crore in FY2025. It also reported a profit after tax of ₹43.83 crore, compared with a loss of ₹57.98 crore in the previous financial year.

This change provides important context for the IPO. Better operating performance can support debt servicing, but a single year’s results should not be viewed in isolation.

Healthcare businesses also need to consider occupancy, patient volumes, payer mix, operating costs, equipment requirements and the time required for new facilities to reach operational maturity.

The sustainability of the financial turnaround will depend on whether the business can maintain operating performance while managing its existing liabilities and future investment commitments.

Expansion Creates a Capital Allocation Challenge

Paras Healthcare has outlined plans to add 800 beds through proposed hospital projects in Gurugram and Ludhiana.

Expansion creates a long-term opportunity, but it also introduces funding and execution requirements. New hospitals need land or premises, equipment, clinical staff, operating systems and sufficient working capital.

They may also take time to build occupancy and generate stable operating cash flows.

This creates a capital allocation question: how should management balance debt repayment with the investment required to expand capacity?

Using equity to reduce debt can create financial flexibility, but the company must still ensure that adequate funding remains available for the next phase of growth.

A financing plan should therefore consider debt obligations, construction schedules, equipment expenditure, operating costs and expected cash generation together.

Five Questions Finance Teams Should Ask Before Raising Equity

The lessons from this transaction apply to companies in many sectors.

1. How much new capital will the company actually receive?

Separate fresh issue proceeds from any OFS component. Assess the net amount available after relevant transaction expenses and other applicable adjustments.

2. Which borrowings will be repaid?

Identify the facilities being repaid, their interest rates, maturity dates, security arrangements and prepayment terms.

3. How will the debt profile change?

Evaluate the resulting borrowing levels, finance costs, repayment schedule and liquidity position. The benefit should be assessed against the company’s remaining obligations.

4. What future capital expenditure remains unfunded?

Prepare a schedule of committed and planned investments. Identify the amount that can be supported by internal accruals and the amount that may require additional borrowing or equity.

5. Will operating cash flow support the plan?

Test whether projected cash generation can cover debt servicing and ongoing investment under realistic scenarios, including slower revenue growth or higher operating costs.

These questions help management assess a capital raise as part of a wider financial strategy rather than as an isolated transaction.

The Credit Rating Connection

Debt repayment can be relevant to a company’s credit risk profile because it may change leverage, finance costs and liquidity.

However, a capital raise or a reduction in borrowings does not automatically lead to a particular credit rating outcome.

Credit Rating Agencies assess the company’s complete financial and business risk profile, including cash flow generation, repayment capacity, sector risks, governance and future funding requirements.

For a company planning an IPO while also maintaining significant borrowings, it is important to explain how the transaction changes its financial position and how future expansion will be funded.

Clear financial projections, a complete debt schedule and consistent supporting information can help management explain the rationale behind its capital allocation decisions.

The Takeaway

Paras Healthcare’s proposed IPO illustrates the different purposes that equity fundraising can serve. It can provide new capital, support debt repayment and create room for future investment, while an OFS allows existing shareholders to sell part of their holdings.

The financial impact should be evaluated against the amount of fresh capital raised, the debt actually repaid and the funding still required for expansion.

For promoters and CFOs, the key is to ensure that capital raising, debt management and business growth are planned together.

FinMen Advisors and Consultants Private Limited supports businesses through structured Credit Rating Advisory, including financial analysis, documentation readiness and preparation for engagement with Credit Rating Agencies.

Disclaimer: This article is for general informational and educational purposes only and does not constitute financial, credit, investment or legal advice. The proposed IPO terms and use of proceeds should be verified against the company’s final offer documents. Credit ratings are assigned independently by SEBI-registered Credit Rating Agencies. FinMen Advisors does not issue, influence or guarantee any rating outcome.